Non-invasive breathing support for COVID-19 patients isn’t linked to heightened infection risk

The use of non-invasive breathing support, commonly known as CPAP or HFNO, to treat moderate to severe COVID-19 infection, isn’t linked to a heightened infection risk, as currently thought, suggest two new studies which included work led by University of Bristol researchers. The findings and a linked editorial are published today in Thorax (4 November).